These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6749531)

  • 21. Unusual pulmonary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with endoperoxides and other prostanoids.
    Hyman AL; Chapnick BM; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5711-5. PubMed ID: 414226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.
    Jackson EK; Heidemann HT; Branch RA; Gerkens JF
    Circ Res; 1982 Jul; 51(1):67-72. PubMed ID: 7044603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of effects of prostaglandins E2 and I2 on rat renal vascular resistance.
    Baer PG; McGiff JC
    Eur J Pharmacol; 1979 Mar; 54(4):359-63. PubMed ID: 374096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actions of prostaglandins in peripheral vascular beds.
    Feigen LP
    Fed Proc; 1981 May; 40(7):1987-90. PubMed ID: 7014257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ; Hintze TH; Kaley G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.
    Nandiwada P; Hyman AL; Feigen LP; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):118-28. PubMed ID: 7190813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypotensive response to prostacyclin and 6-keto-PGE1 following hepatectomy in the rat.
    Van Dam J; Stinger RB; Penhos JC; Ramwell PW; Kot PA
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):438-42. PubMed ID: 6379654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiovascular effects of beraprost sodium (TRK-100), a prostacyclin analogue in the dog].
    Nishio S; Matsuura H; Hattori M; Endoh T; Yamada N; Hirano T; Murai T; Miyao Y; Kanai T; Umetsu T
    Nihon Yakurigaku Zasshi; 1989 Dec; 94(6):351-61. PubMed ID: 2514128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 13, 14-dehydroprostacyclin methyl ester on the feline intestinal vascular bed.
    Paustian PW; Chapnick BM; Feigen LP; Hyman AL; Kadowitz PJ
    Prostaglandins; 1977; 14(6):1141-52. PubMed ID: 341229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary and systemic vascular effects of exogenous prostaglandin I2 in fetal lambs.
    Leffler CW; Hessler JR
    Eur J Pharmacol; 1979 Feb; 54(1-2):37-42. PubMed ID: 369870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prostaglandins on pancreatic circulation in anesthetized dogs.
    Homma T; Malik KU
    J Pharmacol Exp Ther; 1982 Sep; 222(3):623-8. PubMed ID: 7050343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histologic and hemodynamic effects of prostacyclin and prostaglandin E1 following oleic acid infusion.
    Slotman GJ; Machiedo GW; Casey KF; Lyons MJ
    Surgery; 1982 Jul; 92(1):93-9. PubMed ID: 7046123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of intravitreal and topical prostaglandins on intraocular inflammation.
    Kulkarni PS; Srinivasan BD
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):383-92. PubMed ID: 7050005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals.
    Utsunomiya T; Krausz MM; Shepro D; Hechtman HB
    Am J Physiol; 1981 Nov; 241(5):H766-71. PubMed ID: 7030086
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size.
    Jugdutt BI
    Prostaglandins Med; 1981 Nov; 7(5):431-55. PubMed ID: 6798589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of 6-oxo-prostaglandin E1 on human platelet aggregation in whole blood in-vitro.
    Wilsoncroft PS; Lofts FJ; Griffiths RJ; Moore PK
    J Pharm Pharmacol; 1985 Feb; 37(2):139-41. PubMed ID: 2858551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC; Ebert CD; Kim SW
    Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of prostaglandins in the mesenteric vascular bed.
    Chapnick BM; Feigen LP; Hyman AL; Kadowitz PJ
    Am J Physiol; 1978 Sep; 235(3):H326-32. PubMed ID: 358842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.